(12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 4-methylbenzenesulfonate
![BK0B47 | 2136287-68-6 | (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 4-methylbenzenesulfonate](https://qncdn.chemcd.cn/alchemypharm/2136287-68-6.png "BK0B47 | 2136287-68-6 | (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 4-methylbenzenesulfonate")
Catalog No.: BK0B47
CAS.RN：2136287-68-6
Molecular Formula: C23H31N3O7S
Molecular Weight: 493.57 g/mol
Purity: NLT 98%
Intermediates of Baloxavir marboxil
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA63P5 | Baloxavir marboxil API | 1985606-14-1 |
| BK0B47 | (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione 4-methylbenzenesulfonate | 2136287-68-6 |
| BK9M90 | (R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione | 1985607-70-2 |
| BK2DH7 | 7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione | 1370250-39-7 |
| BK2X7N | 7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol | 1985607-83-7 |
| BK6U2D | allyl 3-methoxymorpholine-4-carboxylate | 2119729-43-8 |
| BK8W05 | Baloxavir | 1985605-59-1 |
| BK71J6 | ethyl 1-amino-3-(benzyloxy)-4-oxo-1,4-dihydropyridine-2-carboxylate | 1985607-66-6 |
| BK53PA | 3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | 119736-16-2 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
